Synthetic MR AB (XSAT:SYNT) Capital Expenditure : kr-9.74 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Synthetic MR AB's cash flow for capital expenditures for the three months ended in Dec. 2023 was kr-2.53 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was kr-9.74 Mil.

Synthetic MR AB Capital Expenditure Historical Data

The historical data trend for Synthetic MR AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Capital Expenditure Chart

Synthetic MR AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-3.62

-5.56

-5.22

-10.50

-9.72

Synthetic MR AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capital Expenditure	Get a 7-Day Free Trial															-2.55	-2.82	-2.67	-1.71	-2.53

Synthetic MR AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.74 Mil.

Synthetic MR AB (XSAT:SYNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

N/A

Address

Storgatan 11, Linkoping, SWE, SE-582 23

Website

https://www.syntheticmr.com

Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.